JPS55127353A - Gamma-rearrangement of alpha-glutamylpeptide - Google Patents
Gamma-rearrangement of alpha-glutamylpeptideInfo
- Publication number
- JPS55127353A JPS55127353A JP3336079A JP3336079A JPS55127353A JP S55127353 A JPS55127353 A JP S55127353A JP 3336079 A JP3336079 A JP 3336079A JP 3336079 A JP3336079 A JP 3336079A JP S55127353 A JPS55127353 A JP S55127353A
- Authority
- JP
- Japan
- Prior art keywords
- glutamylpeptide
- protecting group
- reaction
- cooh
- rearrangement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
PURPOSE: To improve the yield of γ-rearragement of α-glutamylpeptide with alkali treatment, by carrying out the reaction in the presence of DMF or DMSO, and to prepare glutathione by using the γ-rearrangement.
CONSTITUTION: An α-glutamylpeptide such as the formula I (R-CO- is amino acid residue, peptide residue, etc. having free NH2 terminal group; NHR' is an amino acid residue or peptide residue having free COOH terminal group; R" is protecting group of COOH), is treated with an alkali in the presence of DMF or DMSO to obtain a γ-glutamylpeptide. The reaction is carried out at 10W40°C. Preferable example of the raw material is a tripeptide of formula II (B is H or SH-protecting group; X is H or NH2-protecting group; Y, D are OH or COOH-protecting group), obtained by an enzymatic synthesis. Glutathione is prepared by eliminating the protecting groups after the γ-rearragement reaction.
COPYRIGHT: (C)1980,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3336079A JPS55127353A (en) | 1979-03-23 | 1979-03-23 | Gamma-rearrangement of alpha-glutamylpeptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3336079A JPS55127353A (en) | 1979-03-23 | 1979-03-23 | Gamma-rearrangement of alpha-glutamylpeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS55127353A true JPS55127353A (en) | 1980-10-02 |
Family
ID=12384410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3336079A Pending JPS55127353A (en) | 1979-03-23 | 1979-03-23 | Gamma-rearrangement of alpha-glutamylpeptide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS55127353A (en) |
-
1979
- 1979-03-23 JP JP3336079A patent/JPS55127353A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT910575E (en) | FUSOGENIC LIPOSOMES | |
ES482414A1 (en) | Process for making 4-aminohex-5-enoic acid | |
JPS5524147A (en) | Peptide derivative | |
DK149091C (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF PEPTIDS CONTAINING 2-7 AMINO ACID RESIDUES, DESAMINODIPEPTIDES OR AMIDES THEREOF WITH UBIQUITIN SIMILAR ACTIVITY OR PHARMACEUTICAL ACCEPTABLE ACID ADDITIONAL SALTS | |
JPS55127353A (en) | Gamma-rearrangement of alpha-glutamylpeptide | |
JPS5488241A (en) | Novel fortimicin a derivative | |
JPS5464692A (en) | Novel synthesis of peptide derivatives | |
IL84195A0 (en) | The synthesis of peptide amino-alkylamides and peptide hydrazides by the solid-phase method and novel compounds thus produced | |
JPS5225768A (en) | Preparation of novel pentapeptides | |
GB1533129A (en) | Process for producing a peptide in the presence of an enzyme | |
CH612180A5 (en) | Process for the preparation of novel pyroglutamyl compounds | |
GB2127831A (en) | Intermediates in the preparation of caerulein | |
JPS57155974A (en) | Preparation of concentrated barley water | |
JPS54135789A (en) | Preparation of human insulin | |
ES2000879A6 (en) | Inorganic acid salt of N-[1(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanylchloride and process for preparing the same. | |
ES8302633A1 (en) | Process for the removal of the formyl group from N-formyl peptides and esters thereof | |
JPS5668610A (en) | Antitumorigenic agent containing napthalenesulfonamide as effective component | |
JPS51138691A (en) | Process for preparing novel b is-penicillins | |
JPS646294A (en) | Novel peptide derivative | |
JPS5777652A (en) | Preparation of peptide and arginine derivative | |
JPS5581896A (en) | Biologically active substance from beefsteak plants of family labiatae and its preparation | |
JPS54112896A (en) | Preparation of maytansines | |
JPS5481202A (en) | Elimination of protecting group | |
JPS57163351A (en) | N-terminal peptide of beta-type interferon | |
JPS5758694A (en) | Monobenzylphosphorylalanylproline and hypotensive comprising it |